Trial record 23 of 80 for: "Adult Acute Lymphocytic Leukemia" | "Antineoplastic Agents, Hormonal"
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02043587|
Recruitment Status : Active, not recruiting
First Posted : January 23, 2014
Last Update Posted : October 19, 2018
University of California, San Diego
Leadiant Biosciences, Inc.
Information provided by (Responsible Party):
Matthew Wieduwilt, M.D., Ph.D., University of California, San Diego
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Estimated Primary Completion Date :||January 2020|
|Estimated Study Completion Date :||January 2020|
Publications of Results: